Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.
about
Holding the Inflammatory System in Check: TLRs and Their Targeted Therapy in AsthmaPotential of PEGylated Toll-Like Receptor 7 Ligands for Controlling Inflammation and Functional Changes in Mouse Models of Asthma and SilicosisThe therapeutic potential of Toll-like receptor 7 stimulation in asthma.TLR3 and TLR7 modulate IgE production in antigen induced pulmonary inflammation via influencing IL-4 expression in immune organs.The transcriptome of Trichuris suis--first molecular insights into a parasite with curative properties for key immune diseases of humans.An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles.Allergen-Associated Immunomodulators: Modifying Allergy Outcome.A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.Development of a novel severe triple allergen asthma model in mice which is resistant to dexamethasone and partially resistant to TLR7 and TLR9 agonist treatment.Upping the antedrug: is a novel anti-inflammatory Toll-like receptor 7 agonist also a bronchodilator?The regulation of allergy and asthma.Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammationPituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice.Transcriptional regulation of cytokine function in airway smooth muscle cells.Primary prevention of allergic diseases: current concepts and mechanisms.Asthma in children and adolescents: a comprehensive approach to diagnosis and management.Pattern-recognition receptors in human eosinophils.Perspectives on immunomodulation early in life.Toll-like receptor-expressing cells for antiallergy compound screening.TLR 7/8 Ligand, S28463, Suppresses Ascaris Suum Induced Allergic Asthma in Nonhuman Primates.Seafood allergen-induced hypersensitivity at the microbiota-mucosal site: Implications for prospective probiotic use in allergic response regulation.IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod).Modulation of the allergic asthma transcriptome following resiquimod treatment.TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway.Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model.
P2860
Q26747627-D6C4462D-604E-4354-90AA-957AEE426C65Q28389397-04FE4333-2EA4-4CDC-9B9D-AA654DDE0032Q33725167-81CD0D1F-B0C7-4023-AD6B-4D9CE69A8815Q33833904-1BE05CE3-A958-4B92-AB0C-E236E8F74F91Q34009430-491550C6-B14E-46B1-AAFD-EFDDBAD99F1BQ34431983-979C9E1C-51D2-4ECE-BD27-30D18D4D3D51Q34526523-FC788412-0B42-44A5-8BF7-EEF2751AA225Q34564412-90031D19-179B-4667-8EA2-B9045F790A88Q34602052-7A7B69A2-B47A-4FC3-B34D-471FEFE09171Q35117670-837EBF39-802E-4577-A811-55BE0C04136AQ36159164-F0D2FCFC-830D-43F3-9B8C-1641B4E9A9B0Q36563540-58691117-74FD-4EFE-9AB9-547FE3C63418Q36870120-FDB5854D-D76A-4AAE-B661-C5DD0458DBAAQ36959866-88F0BCA4-DD48-4CC8-94FB-F316FAEA1ECFQ37329286-94D8463F-EF87-46BF-9271-1DFA3CB171F5Q37762858-62CA4909-4A08-49B7-9FDF-36C7867B1B3EQ37970318-05F7AD75-E4CD-45D1-BD0A-F3300D0F4C87Q37975547-2EC4692D-33CE-45A4-8325-7B58F63EEAC9Q37980790-556726E0-F2CD-4B24-B47A-E06D918EFCB3Q38090669-54D6F652-E9DB-457A-B6A8-F9F17D369BFEQ38603989-C47F2CCB-7F0B-41BB-ADD1-21BE4CB199B8Q38770847-FB6204ED-0B58-469A-BF8B-7A1AC1F3D97CQ39229985-609F00AE-88B4-43E2-A39B-24498B4FC5C2Q45985404-986F7855-AB6D-4EC9-9AAD-B4C9708F9132Q46856473-C6AEB3FB-09FF-4023-9E1B-2F3D6C3BA4EBQ51767255-34287897-9BA9-4E9E-A187-92068972ADA8
P2860
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Resiquimod, a new immune respo ...... rway hyper-reactivity in mice.
@en
Resiquimod, a new immune respo ...... rway hyper-reactivity in mice.
@nl
type
label
Resiquimod, a new immune respo ...... rway hyper-reactivity in mice.
@en
Resiquimod, a new immune respo ...... rway hyper-reactivity in mice.
@nl
prefLabel
Resiquimod, a new immune respo ...... rway hyper-reactivity in mice.
@en
Resiquimod, a new immune respo ...... rway hyper-reactivity in mice.
@nl
P2093
P2860
P1476
Resiquimod, a new immune respo ...... rway hyper-reactivity in mice.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2222.2004.02023.X
P577
2004-08-01T00:00:00Z